Biofrontera (BFRI) Debt Ratio (2021 - 2024)

Biofrontera (BFRI) recorded quarterly Debt Ratio of 0.01 in Q2 2024, down 85.68% quarter-over-quarter from 0.1 in Q1 2024.

Biofrontera (BFRI) Debt Ratio (2021 - 2024) Analysis & Trends

Biofrontera's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.01 for Q2 2024.

  • In Q2 2024, Debt Ratio changed N/A year-over-year to 0.01; the TTM figure through Jun 2024 stood at 0.01 (changed N/A YoY), while the FY2023 annual figure was 0.14, up 2.45% from the prior year.
  • Debt Ratio was 0.01 for Q2 2024 at Biofrontera, down from 0.1 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.21 in Q3 2023 to a low of 0.01 in Q2 2024.
  • Historically, Debt Ratio has averaged 0.11 across 4 years, with a median of 0.12 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Debt Ratio jumped 259.09% in 2023, then tumbled 42.81% in 2024.
  • A 4-year view of Debt Ratio shows it stood at 0.06 in 2021, then surged by 123.95% to 0.14 in 2022, then advanced by 2.45% to 0.14 in 2023, then plunged by 90.18% to 0.01 in 2024.
  • The last three Debt Ratio figures came in at 0.01 (Q2 2024), 0.1 (Q1 2024), and 0.14 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 Biofrontera 8.65 Mn 2.24 Mn 14.09 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 0.01
Mar 31, 2024 0.10
Dec 31, 2023 0.14
Sep 30, 2023 0.21
Mar 31, 2023 0.17
Dec 31, 2022 0.14
Sep 30, 2022 0.06
Dec 31, 2021 0.06